DAWN - Day One Biopharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

DAWN is currently covered by 7 analysts with an average price target of $29.88. This is a potential upside of $14.09 (89.23%) from yesterday's end of day stock price of $15.79.

Day One Biopharmaceuticals's activity chart (see below) currently has 3 price targets and 33 ratings on display. The stock rating distribution of DAWN is 96.67% BUY and 3.33% SELL.

Stock Analyst Price Targets - Review

Highest price target for DAWN is $44, Lowest price target is $9, average price target is $29.88.

Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 26-Mar-2024.

Currently out of the existing stock ratings of DAWN, 29 are a BUY (96.67%), 1 are a SELL (3.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

40

$24.21 (153.32%)

40

2 days ago

0/6 (0%)

$24.48 (157.73%)

Buy

44

$28.21 (178.66%)

54

1 months 1 days ago

0/4 (0%)

$26.62 (153.16%)

Buy

35

$19.21 (121.66%)

38

4 months 21 days ago

0/5 (0%)

$22.64 (183.17%)

Buy

34

$18.21 (115.33%)

34

4 months 21 days ago

0/8 (0%)

$21.64 (175.08%)

Sell

9

$-6.79 (-43.00%)

34

11 months 3 days ago

0/2 (0%)

$-2.74 (-23.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DAWN (Day One Biopharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?

ERINN MURPHY

Which analyst has the most public recommendations on DAWN (Day One Biopharmaceuticals)?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on DAWN

Which analyst is the currently most bullish on DAWN (Day One Biopharmaceuticals)?

Andrea Tan with highest potential upside - $28.21

Which analyst is the currently most reserved on DAWN (Day One Biopharmaceuticals)?

Alec Stranahan with lowest potential downside - -$6.79

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?